Promotion of cross-disciplinary research
We are labeling small molecules (sodium salts), medium molecules (amino acid derivatives, transporter inhibitors), and macromolecules (antibodies, etc.) with short-lived radionuclides and evaluating their functions with the aim of applying them as nuclear medicine therapeutics.
In collaboration not only with laboratories within the Department of Chemistry, but also with the Graduate School of Medicine, the Graduate School of Engineering, the National Institute of Radiological Sciences, and the Research Center for Nuclear Physics, we are involved in the production and separation of nuclides, synthesis and labeling of compounds, and evaluation using living organisms (cells and experimental animals).
In addition to this, we continue to analyze the function of LAT1, an amino acid transporter that is specifically induced in cancer cells and is one of the molecular targets of nuclear medicine drugs, in an attempt to elucidate the significance of the expression of this molecule in cancer and to develop better therapeutic drugs.